Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: A preliminary report

International Journal of Artificial Organs

Volumn 33, Issue 1, 2010, Pages 22-29

  Gong, Dehua ^a   Zhang, Peng ^b   Ji, Daxi ^a   Chen, Zhaohong ^a   Li, Weiqin ^a   Li, Jieshou ^a   Li, Leishi ^a   Liu, Zhihong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; High volume hemofiltration; Severe acute pancreatitis; Systemic inflammatory response syndrome

Indexed keywords

BLOOD; CYTOLOGY; GLYCOPROTEINS; INTENSIVE CARE UNITS; PATIENT MONITORING;

CELL COUNT; CYTOKINES; GENERAL SURGERY; HEMOFILTRATION; HIGH VOLUMES; HIGH-VOLUME HEMOFILTRATION; INTERLEUKIN1; SEVERE ACUTE PANCREATITIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES; TUMOR NECROSIS FACTORS;

T-CELLS;

ANTIINFLAMMATORY AGENT; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PROTEINASE INHIBITOR;

ACUTE PANCREATITIS; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUID THERAPY; GASTRIC SUCTION; HEMOFILTRATION; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; LYMPHOCYTE COUNT; MALE; MONOCYTE; NUTRITIONAL SUPPORT; PALLIATIVE THERAPY; PERITONEUM LAVAGE; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT RESPONSE;

EID: 77649256737     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300104     Document Type: Article

References (22)

1. Beger HG, Rau BM. Severe acute pancreatitis: clinical course and management. World J Gastroenterol 2007; 13: 5043-51.
2. Yasuda T, Ueda T, Takeyama Y, et al. Long-term outcome of severe acute pancreatitis. J Hepatobiliary Pancreat Surg 2008; 15: 397-402.
3. Al-Mofleh IA. Severe acute pancreatitis: pathogenetic aspects and prognostic factors. World J Gastroenterol 2008; 14: 675-84.
4. Wereszczynska-Siemiatkowska U, Mroczko B, Siemiatkowski A. Serum profiles of interleukin-18 in different severity forms of human acute pancreatitis. Scand J Gastroenterol 2002; 37: 1097-102.
5. Jambrik Z, Gyöngyösi M, Hegyi P, et al. Plasma levels of IL-6 correlate with hemodynamic abnormalities in acute pancreatitis in rabbits. Intensive Care Med 2002; 28: 1810-8.
6. Jiang CF, Shiau YC, Ng KW, Tan SW. Serum interleukin-6, tumor necrosis factor alpha and C-reactive protein in early prediction of severity of acute pancreatitis. J Chin Med Assoc 2004; 67: 442-6.
7. Han XC, Zhang YC, Wang Y, Jia MK. Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int 2003; 2: 135-8.
8. Mentula P, Kylänpää ML, Kemppainen E, et al. Plasma anti-inflammatory cytokines and monocyte human leucocyte antigen-DR expression in patients with acute pancreatitis. Scand J Gastroenterol 2004; 39: 178-87.
9. Rau BM, Kruger CM, Schilling MK. Anti-cytokine strategies in acute pancreatitis: pathophysiological insights and clinical implications. Rocz Akad Med Bialymst 2005; 50: 106-15.
10. Yu C, Liu ZH, Chen ZH, Gong DH, Ji DX, Li LS. Improvement of monocyte function and immune homeostasis by high volume continuous venovenous hemofiltration in patients with severe acute pancreatitis. Int J Artif Organs 2008; 31: 882-90.
11. Chen ZH, Liu ZH, Yu C, Ji DX, Li LS. Endothelial dysfunction in patients with severe acute pancreatitis: improved by continuous blood purification therapy. Int J Artif Organs 2007; 30: 393-400.
12. Pietruczuk M, Dabrowska MI, Wereszczynska-Siemiatkowska U, Dabrowski A. Alteration of peripheral blood lymphocyte subsets in acute pancreatitis. World J Gastroenterol 2006; 12: 5344-51.
13. Kylanpaa ML, Mentula P, Kemppainen E, et al. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-γ in vitro. Pancreas 2005; 31: 23-7.
14. Satoh A, Miura T, Satoh K, et al. Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 2002; 25: 245-50.
15. Ho YP, Sheen IS, Chiu CT, Wu CS, Lin CY. A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 2006; 101: 1117-24.
16. Monneret G, Finck ME, Venet F, et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 2004; 95: 193-8.
17. Smith JW, Gamelli RL, Jones SB, Shakar R. Immunologic responses to critical injury and sepsis. J Intensive Care Med 2006; 21: 160-72.
18. Mentula P, Kylänpää-Bäck M, Kemppainen E, et al. Decreased HLA (human leukocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis. Clin Sci (Lond) 2003;105: 409-17.
19. Ueda T, Takeyama Y, Yasuda T, Takase K, Nishikawa J, Kuroda Y. Functional alterations of splenocytes in severe acute pancreatitis. J Surg Res 2002; 102: 161-8.
20. Nakada T, Oda S, Matsuda K, et al. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med 2008; 14: 257-73.
21. Vriese ASD, Colardyn FA, Philippe JJ, Vanholder RC, Sutter JHD, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999; 10: 846-53.
22. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11: 161-7.